DCM
QTTB icon

Dupont Capital Management’s Q32 Bio QTTB Stock Holding History

Dupont Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,598
Closed -$368K – 1855
2021
Q3 		$368K Sell
2,598
-367
-12% -$46.8K 0.01% 1009
2021
Q2 		$388K Buy
+2,965
New +$370K 0.01% 1106

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dupont Capital Management's QTTB Position: Q4 2021 in Review

Dupont Capital Management sold out of Q32 Bio (QTTB) in Q4 2021, closing a stake of 2,598 shares — an estimated $368K sold.

Dupont Capital Management first reported a position in QTTB in Q2 2021 and held it in 2 quarters. The position peaked at $388K in Q2 2021. 120 funds tracked by Wall St. Rank hold QTTB as of Q4 2021.

  • Dupont Capital Management reported no remaining Q32 Bio position as of Q4 2021 after selling out during the quarter.
  • Dupont Capital Management sold 2,598 Q32 Bio shares in Q4 2021, an estimated $368K.
  • Dupont Capital Management first reported a position in Q32 Bio in Q2 2021 and held it in 2 quarters.
  • Dupont Capital Management's Q32 Bio position peaked at $388K in Q2 2021.
  • 120 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2021.

Based on Dupont Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.